Triad Wealth Partners LLC Acquires New Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Triad Wealth Partners LLC bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 4,514 shares of the pharmacy operator’s stock, valued at approximately $55,000.

A number of other hedge funds have also recently made changes to their positions in WBA. Atlas Brown Inc. boosted its stake in shares of Walgreens Boots Alliance by 1.8% in the 1st quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock valued at $685,000 after purchasing an additional 550 shares during the last quarter. Westpac Banking Corp increased its holdings in Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock worth $159,000 after purchasing an additional 560 shares in the last quarter. Shilanski & Associates Inc. lifted its stake in Walgreens Boots Alliance by 5.3% in the first quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock valued at $256,000 after buying an additional 591 shares during the period. First Trust Direct Indexing L.P. grew its position in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock worth $696,000 after buying an additional 597 shares during the period. Finally, NBC Securities Inc. increased its stake in shares of Walgreens Boots Alliance by 9.9% in the 4th quarter. NBC Securities Inc. now owns 6,757 shares of the pharmacy operator’s stock valued at $176,000 after acquiring an additional 611 shares in the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA traded up $0.10 during midday trading on Friday, reaching $10.92. 11,044,161 shares of the company traded hands, compared to its average volume of 15,507,391. The firm’s fifty day moving average price is $12.45 and its two-hundred day moving average price is $16.97. The firm has a market capitalization of $9.43 billion, a price-to-earnings ratio of -1.62, a price-to-earnings-growth ratio of 0.73 and a beta of 0.72. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a 12 month low of $10.19 and a 12 month high of $28.26.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The firm had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business’s revenue was up 2.8% on a year-over-year basis. During the same period last year, the company posted $1.00 EPS. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 9.16%. The ex-dividend date is Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -14.84%.

Analysts Set New Price Targets

A number of brokerages have commented on WBA. UBS Group reduced their price objective on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research note on Wednesday, July 3rd. Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. JPMorgan Chase & Co. reduced their price objective on shares of Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating for the company in a report on Monday, July 1st. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a report on Friday, June 28th. Finally, TD Cowen cut their price target on Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a research note on Monday, July 1st. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $16.86.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.